RecruitingNot applicable

Evaluating the Impact of CONNECT in a Multilingual Population

Evaluating the Impact of CONNECT, a Novel Smoking Cessation Intervention, in a Diverse, Multilingual Population

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
50 Years to 80 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Interviews

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Interviews will be recorded, transcribed and translated."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study will develop and test CONNECT ML, a program to help Spanish- and Cantonese-speaking adults quit smoking during lung cancer screening. The program offers a video doctor with personal responses, text and phone support, and help from a pharmacist to get nicotine replacement medicine.

This study aims to broaden the reach of the lung cancer screening (LCS) CONNECT program (NCT04149249, NCT06213532), by developing a version of the program to be available to multilingual communities. The CONNECT program encourages individuals who are undergoing lung cancer screening to also quit smoking by providing a personalized program which includes a video doctor with personalized responses, text message and telephone call support and connection with a pharmacist to assist in obtaining nicotine replacement medication. This clinical trial will develop and ultimately test how well the CONNECT Multilingual (CONNECT ML) program works to improve smoking cessation among current adult smokers within the Spanish and Cantonese speaking communities.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Are 50 to 80 years old.
  • Have smoked at least one cigarette in the past 7 days.
  • Qualify for lung cancer screening with at least 20 pack-years of smoking, such as one pack a day for 20 years.
  • Live in California.
  • Can understand and follow study steps for the whole study.
  • You or your legal guardian or representative can understand the written consent form and are willing to sign it.

Who can't join

  • Do not currently smoke.
  • Have been diagnosed with lung cancer.
  • Are receiving hospice care, which focuses on comfort near the end of life.
  • Your health care provider thinks you should not join, such as because mental health, memory, or thinking problems would keep you from taking part.
  • Have hearing or vision problems that would keep you from using parts of the program, such as video or phone counseling.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Age 50-80 years old. * Current smokers defined at smoking at least one cigarette in past 7 days AND eligible for lung cancer screening (LCS) based on smoking history (\>=20 pack year history) * California (CA) residents * Able to understand and comply with study procedures for the entire length of the study. * Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: * Non-smokers. * Individuals with a diagnosis of lung cancer. * Individuals receiving hospice care. * Individuals whose providers do not think that they should participate (e.g., psychiatric illness or significant cognitive impairment that would impede the individuals ability to participate). * Hearing and/or vision disabilities that would prevent participants from adequately receiving treatment components such as video or telephone counseling.

Study sites (1)

CA